Stepan Reports First Quarter 2026 Results
Get Alerts SCL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.1%
EPS Growth %: +17.3%
Join SI Premium – FREE
First Quarter 2026 Highlights
- Reported net income was a
$41.4 million loss versus$19.7 million of income in the prior year. The current year loss resulted from a previously announced$65.4 million pre-tax restructuring charge. Adjusted net income(1) was$10.3 million , down 47% versus the prior year, largely due to lower Surfactant earnings and higher interest expense. The higher interest expense reflects lower capitalized interest income due to the start-up of thePasadena, TX site. - EBITDA(2) was a negative
$16.5 million versus$58.0 million in the prior year. Current year EBITDA was negatively impacted by the$65.4 million restructuring charge. Adjusted EBITDA(2) was$49.6 million , down 14% year-over-year. - Organic sales volume was flat year-over-year as strong demand within Crop Productivity, Oilfield and Industrial Cleaning was offset by soft European Polymers demand.
- Cash from Operations was
$16.9 million during the quarter. Free cash flow(3) for the quarter was a negative$14.0 million , driven by higher working capital requirements which are typical during the first quarter. - Pre-tax earnings include a
$65.4 million restructuring charge related to the previously announced closure of the Company'sFieldsboro, NJ site and select assets at its Elwood (Millsdale), IL and Stalybridge,UK facilities. The cash impact associated with this restructuring charge was less than$1.0 million during the quarter. - The Company has entered into an agreement to sell a parcel of land near its Millsdale site for
$30 million . This agreement is subject to customary closing conditions and the transaction is expected to close during the second half of the year.
"We are executing Project Catalyst safely and in line with expectations despite early quarter weather-related impacts and the new geopolitical challenges. Global adjusted EBITDA was down
Financial Summary
Three Months Ended | ||||||||||||
($ in thousands, except per share data) | 2026 | 2025 | % | |||||||||
$ | 604,509 | $ | 593,255 | 2 | % | |||||||
Operating Income (Loss) | $ | (49,622) | $ | 28,288 | NM | |||||||
Net Income (Loss) | $ | (41,406) | $ | 19,711 | NM | |||||||
Earnings per Diluted Share | $ | (1.81) | $ | 0.86 | NM | |||||||
Adjusted Net Income * | $ | 10,313 | $ | 19,310 | (47) | % | ||||||
Adjusted Earnings per | $ | 0.45 | $ | 0.84 | (46) | % | ||||||
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in
Net sales in the first quarter of 2026 increased 2% year-over-year. This increase reflects higher selling prices and the favorable impact of foreign currency translation. A 3% decline in sales volume partially offset the above. Organic volume was flat and organic net sales were up 4% year-over-year.
Three Months Ended | ||||
Volume | (3) | % | ||
Selling Price & Mix | 1 | % | ||
Foreign Translation | 4 | % | ||
Total | 2 | % | ||
Segment Results
Three Months Ended | ||||||||||||
($ in thousands) | 2026 | 2025 | % | |||||||||
Surfactants | $ | 453,687 | $ | 430,337 | 5 | % | ||||||
Polymers | $ | 130,029 | $ | 146,116 | (11) | % | ||||||
Specialty Products | $ | 20,793 | $ | 16,802 | 24 | % | ||||||
Total | $ | 604,509 | $ | 593,255 | 2 | % | ||||||
Three Months Ended | ||||||||||||
($ in thousands, all amounts pre-tax) | 2026 | 2025 | % | |||||||||
Operating Income (Loss) | ||||||||||||
Surfactants | $ | 18,548 | $ | 28,930 | (36) | % | ||||||
Polymers | $ | 8,822 | $ | 8,018 | 10 | % | ||||||
Specialty Products | $ | 4,715 | $ | 5,508 | (14) | % | ||||||
Total Segment | $ | 32,085 | $ | 42,456 | (24) | % | ||||||
Corporate Expenses | $ | (81,707) | $ | (14,168) | 477 | % | ||||||
Consolidated | $ | (49,622) | $ | 28,288 | (275) | % | ||||||
Three Months Ended | ||||||||||||
($ in millions) | 2026 | 2025 | % | |||||||||
EBITDA | $ | (16.5) | $ | 58.0 | (128) | % | ||||||
Adjusted EBITDA | ||||||||||||
Surfactants | $ | 41.1 | $ | 48.3 | (15) | % | ||||||
Polymers | $ | 17.4 | $ | 16.1 | 8 | % | ||||||
Specialty Products | $ | 6.2 | $ | 7.0 | (11) | % | ||||||
Unallocated Corporate | $ | (15.1) | $ | (13.9) | 9 | % | ||||||
Consolidated Adjusted EBITDA | $ | 49.6 | $ | 57.5 | (14) | % | ||||||
Consolidated adjusted EBITDA(2) decreased
- Surfactant net sales were
$453.7 million for the quarter, up 5% versus the prior year. Selling prices were up 2% primarily due to pass through of higher raw material costs, improved product and customer mix, along with pricing actions. Organic sales volume was up 2%, driven by strong demand within the Industrial Cleaning, Oilfield and Crop Productivity end markets. Total sales volume declined 2% due tothe Philippines divestiture in the fourth quarter of 2025. The Company achieved volume growth in all global regions except Asia. Foreign currency translation positively impacted net sales by 5%. Surfactant adjusted EBITDA(2) for the quarter decreased$7.2 million , or 15%, versus the prior year. This decrease was primarily due to higher overhead due to production timing differences inAsia , competitive pressures inMexico , the severe cold snap in theU.S. and higher oleochemicals raw material costs. - Polymer net sales were
$130.0 million for the quarter, an 11% decrease versus the prior year. Selling prices decreased 8%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume decreased 6% in the quarter. North American sales volume was up 5% but this was more than offset by a 19% decline in Europe. Foreign currency translation positively impacted net sales by 3% during the quarter. Polymer adjusted EBITDA(2) increased$1.3 million , or 8%, versus the prior year primarily due to global margin improvement. - Specialty Products net sales were
$20.8 million for the quarter, a 24% increase versus the prior year, primarily due to higher sales volume. Specialty Products adjusted EBITDA(2) decreased$0.8 million , or 11%. The decrease in adjusted EBITDA(2) was primarily due to product mix and lower margins within the medium chain triglycerides product line due to higher raw material costs.
Outlook
"We are executing on Project Catalyst, which is our comprehensive plan designed to further optimize our asset base and create a more productive and agile organization to enable growth. During the first quarter we executed our plans to close our
Notes
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.
(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was
Conference Call
Stepan Company will host a conference call to discuss its first quarter results at
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; our ability to realize cost savings or operating efficiencies associated with strategic initiatives; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including changes in global trade policies, tariffs, retaliatory measures and countermeasures, currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; potential adverse tax consequences due to the international scope of our business; downgrades in our credit ratings or our ability to access capital markets; global political, military, security or other instability and increased security regulations; costs, delays and miscalculations in capacity needs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants. In addition to the risks described in the Company's periodic reports, the restructuring actions described herein may involve risks related to the execution of facility closures and asset decommissioning, potential operational disruptions, impacts on employees and local communities, environmental compliance, and the realization of anticipated cost savings and efficiencies.
These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.
* * * * *
Tables follow
Table I | ||||||||
STEPAN COMPANY | ||||||||
For the Three Months Ended March 31, 2026 and 2025 | ||||||||
(Unaudited – in 000's, except per share data) | ||||||||
Three Months Ended | ||||||||
2026 | 2025 | |||||||
$ | 604,509 | $ | 593,255 | |||||
Cost of Sales | 539,658 | 517,792 | ||||||
Gross Profit | 64,851 | 75,463 | ||||||
Operating Expenses: | ||||||||
Selling | 12,166 | 12,108 | ||||||
Administrative | 21,313 | 21,414 | ||||||
Research, Development and Technical Services | 14,993 | 14,649 | ||||||
Deferred Compensation Expense | 562 | (996) | ||||||
49,034 | 47,175 | |||||||
Business Restructuring | 65,439 | - | ||||||
Operating Income (Loss) | (49,622) | 28,288 | ||||||
Other Income (Expense): | ||||||||
Interest, Net | (5,011) | (4,126) | ||||||
Other, Net | 144 | 502 | ||||||
(4,867) | (3,624) | |||||||
Income (Loss) Before Provision for Income Taxes | (54,489) | 24,664 | ||||||
Provision for Income Taxes | (13,083) | 4,953 | ||||||
Net Income (Loss) | (41,406) | 19,711 | ||||||
Net Income (Loss) Per Common Share | ||||||||
Basic | $ | (1.81) | $ | 0.86 | ||||
Diluted | $ | (1.81) | $ | 0.86 | ||||
Shares Used to Compute Net Income Per | ||||||||
Basic | 22,888 | 22,867 | ||||||
Diluted | 22,888 | 22,890 | ||||||
Table II | ||||||||||||||||
Reconciliation of Non-GAAP Net Income (Loss) and Earnings per Diluted Share* | ||||||||||||||||
Three Months Ended | ||||||||||||||||
($ in thousands, except per share amounts) | 2026 | EPS | 2025 | EPS | ||||||||||||
Net Income (Loss) Reported | $ | (41,406) | $ | (1.81) | $ | 19,711 | $ | 0.86 | ||||||||
Deferred Compensation (Income) Expense | $ | 477 | $ | 0.02 | $ | (470) | $ | (0.02) | ||||||||
Environmental Remediation | $ | 78 | $ | 0.00 | $ | 69 | $ | 0.00 | ||||||||
Business Restructuring | $ | 51,164 | $ | 2.24 | $ | - | $ | - | ||||||||
Adjusted Net Income | $ | 10,313 | $ | 0.45 | $ | 19,310 | $ | 0.84 | ||||||||
* All amounts in this table are presented after-tax |
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended
Summary of First Quarter 2026 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The first quarter of 2026 reported net income includes
$0.5 million of after-tax expense versus$0.5 million of after-tax income in the prior year. - Environmental Remediation: The first quarter of 2026 reported net income includes
$0.1 million of after-tax expense versus$0.1 million of after-tax expense in the prior year. - Business Restructuring: The first quarter of 2026 reported net income includes
$51.2 million of after-tax expense related to restructuring charges. There were no restructuring charges recognized in the prior year quarter.
Table III | ||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments | ||||||||||||||||
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect is typically calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. | ||||||||||||||||
Three Months Ended | ||||||||||||||||
($ in thousands, except per share amounts) | 2026 | EPS | 2025 | EPS | ||||||||||||
Pre-Tax Adjustments | ||||||||||||||||
Deferred Compensation (Income) Expense | $ | 628 | $ | (626) | ||||||||||||
Environmental Remediation Expense | $ | 102 | $ | 92 | ||||||||||||
Business Restructuring | $ | 65,439 | $ | - | ||||||||||||
Total Pre-Tax Adjustments | $ | 66,169 | $ | (534) | ||||||||||||
Cumulative Tax Effect on Adjustments | $ | (14,450) | $ | 133 | ||||||||||||
After-Tax Adjustments | $ | 51,719 | $ | 2.26 | $ | (401) | $ | (0.02) | ||||||||
Table IV | ||||||||||||||||||||
Deferred Compensation Plans | ||||||||||||||||||||
The full effect of the deferred compensation plans on quarterly pre-tax income was | ||||||||||||||||||||
2026 | 2025 | |||||||||||||||||||
3/31 | 12/31 | 9/30 | 6/30 | 3/31 | ||||||||||||||||
Stepan Company | $ | 49.98 | $ | 47.36 | $ | 47.70 | $ | 54.58 | $ | 55.04 | ||||||||||
Three Months Ended | ||||||||
($ in thousands) | 2026 | 2025 | ||||||
Deferred Compensation | ||||||||
Operating Income (Expense) | $ | (562) | $ | 996 | ||||
Other, net – Mutual Fund Gain (Loss) | (66) | (370) | ||||||
Total Pre-Tax | $ | (628) | $ | 626 | ||||
Total After-Tax | $ | (477) | $ | 470 | ||||
Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into
($ in millions) | Three Months Ended | Change | Change | |||||||||||||
2026 | 2025 | |||||||||||||||
$ | 604.5 | $ | 593.3 | $ | 11.2 | $ | 25.3 | |||||||||
Gross Profit | 64.9 | 75.5 | $ | (10.6) | 2.5 | |||||||||||
Operating Income | (49.6) | 28.3 | $ | (77.9) | 1.3 | |||||||||||
Pretax Income | (54.5) | 24.7 | $ | (79.2) | 1.4 | |||||||||||
Corporate Expenses
Three Months Ended | ||||||||||||
($ in thousands) | 2026 | 2025 | % | |||||||||
Total Corporate Expenses | $ | 81,707 | $ | 14,168 | 477 | % | ||||||
Less: | ||||||||||||
Deferred Compensation (Income) Expense | $ | 562 | $ | (996) | (156) | % | ||||||
Environmental Remediation | $ | 102 | $ | 92 | 11 | % | ||||||
Business Restructuring | $ | 65,439 | $ | - | NM | |||||||
Adjusted Corporate Expenses | $ | 15,604 | $ | 15,072 | 4 | % | ||||||
Table V | ||||||||
Stepan Company | ||||||||
Consolidated Balance Sheets | ||||||||
March 31, 2026 and December 31, 2025 | ||||||||
March 31, 2026 | December 31, | |||||||
ASSETS | ||||||||
Current Assets | $ | 906,238 | $ | 858,959 | ||||
Property, Plant & Equipment, Net | 1,148,164 | 1,219,627 | ||||||
Other Assets | 278,935 | 279,116 | ||||||
Total Assets | $ | 2,333,337 | $ | 2,357,702 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities | $ | 720,453 | $ | 666,494 | ||||
Deferred Income Taxes | 11,052 | 11,450 | ||||||
Long-term Debt | 328,415 | 340,975 | ||||||
Other Non-current Liabilities | 80,393 | 94,773 | ||||||
Total Stepan Company Stockholders' Equity | 1,193,024 | 1,244,010 | ||||||
Total Liabilities and Stockholders' Equity | $ | 2,333,337 | $ | 2,357,702 | ||||
Selected Balance Sheet Information
The Company's total debt increased by
($ in millions) |
| December 31, | ||||||
Net Debt | ||||||||
Total Debt | $ | 651.7 | $ | 626.7 | ||||
Cash | 140.8 | 132.7 | ||||||
Net Debt | $ | 510.9 | $ | 494.0 | ||||
Equity | 1,193.0 | 1,244.0 | ||||||
Net Debt + Equity | $ | 1,703.9 | $ | 1,738.0 | ||||
Net Debt / (Net Debt + Equity) | 30 | % | 28 | % | ||||
The major working capital components were:
($ in millions) |
| December 31, | ||||||
Net Receivables | $ | 433.7 | $ | 388.0 | ||||
Inventories | 289.0 | 298.8 | ||||||
Accounts Payable | (285.7) | (261.7) | ||||||
$ | 437.0 | $ | 425.1 | |||||
Table VI | ||||||||||||||||||||
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA | ||||||||||||||||||||
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income. | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
($ in millions) | Surfactants | Polymers | Specialty | Unallocated | Consolidated | |||||||||||||||
Operating Income (Loss) | $ | 18.5 | $ | 8.8 | $ | 4.7 | $ | (81.7) | $ | (49.6) | ||||||||||
Depreciation and Amortization | 22.6 | 8.6 | 1.5 | 0.4 | 33.0 | |||||||||||||||
Other, Net Income | - | - | - | 0.1 | 0.1 | |||||||||||||||
EBITDA | $ | (16.5) | ||||||||||||||||||
Deferred Compensation | - | - | - | 0.6 | 0.6 | |||||||||||||||
Environmental Remediation | - | - | - | 0.1 | 0.1 | |||||||||||||||
Business Restructuring | - | - | - | 65.4 | 65.4 | |||||||||||||||
Adjusted EBITDA | $ | 41.1 | $ | 17.4 | $ | 6.2 | $ | (15.1) | $ | 49.6 | ||||||||||
Three Months Ended | ||||||||||||||||||||
($ in millions) | Surfactants | Polymers | Specialty | Unallocated | Consolidated | |||||||||||||||
Operating Income | $ | 28.9 | $ | 8.0 | $ | 5.5 | $ | (14.2) | $ | 28.2 | ||||||||||
Depreciation and Amortization | 19.4 | 8.1 | 1.5 | 0.3 | 29.3 | |||||||||||||||
Other, Net Income | - | - | - | 0.5 | 0.5 | |||||||||||||||
EBITDA | $ | 58.0 | ||||||||||||||||||
Deferred Compensation | - | - | - | (0.6) | (0.6) | |||||||||||||||
Environmental Remediation | - | - | - | 0.1 | 0.1 | |||||||||||||||
Adjusted EBITDA | $ | 48.3 | $ | 16.1 | $ | 7.0 | $ | (13.9) | $ | 57.5 | ||||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-first-quarter-2026-results-302755237.html
SOURCE Stepan Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- ORNELLAIA VENDEMMIA D'ARTISTA: THE CHARITY AUCTION RAISES 300,000 DOLLARS, WHICH WILL BE DONATED TO SUPPORT THE SOLOMON R. GUGGENHEIM FOUNDATION
- Royce Global Trust (NYSE: RGT) as of May 31, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share